Physician profile
Adeela Ansari
NPI 1427234012
$4,317.77
in general payments reported to CMS, 2019-2025
24 companies · $178 in 2025
The $178 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,113 · 2020: $816 · 2021: $780 · 2022: $1,021 · 2023: $138 · 2024: $272 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $556 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $555.70 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,346.85 | 2019-2025 | Ozempic |
| Tandem Diabetes Care, INC. | $509.36 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $491.02 | 2020-2023 | Omnipod |
| Dexcom, INC. | $213.14 | 2021-2025 | Dexcom G6 Transmitter |
| Antares Pharma, INC. | $205.11 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $202.87 | 2019-2020 | |
| Lilly USA, LLC | $181.13 | 2019-2022 | |
| Abbott Laboratories | $171.48 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $160.00 | 2019-2020 | |
| Mannkind Corporation | $149.22 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $103.04 | 2020-2022 | |
| Sequel Med Tech, LLC | $82.45 | 2025 | Twiist |
| Medtronic, INC. | $81.81 | 2021-2025 | Minimed 780g |
| Lifescan, INC. | $77.18 | 2020-2022 | |
| Amarin Pharma, INC. | $70.91 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $44.98 | 2020-2021 | |
| Ibsa Pharma INC. | $41.61 | 2019-2020 | |
| Companion Medical, INC. | $33.18 | 2019 | |
| Becton, Dickinson and Company | $32.19 | 2022 | |
| Medtronic Minimed, INC. | $27.54 | 2019 | |
| Amgen INC. | $25.32 | 2019 | |
| Radius Health, INC. | $24.47 | 2019 | |
| Xeris Pharmaceuticals, INC. | $21.59 | 2024 | Recorlev |
| Zealand Pharma US, INC. | $21.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adeela Ansari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.